First Time Loading...

Femasys Inc
NASDAQ:FEMY

Watchlist Manager
Femasys Inc Logo
Femasys Inc
NASDAQ:FEMY
Watchlist
Price: 1.47 USD -2%
Updated: Mar 28, 2024

Intrinsic Value

FEMY doesn't have a meaningful market cap.
FEMY's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. [ Read More ]

The intrinsic value of one FEMY stock under the Base Case scenario is 1.46 USD. Compared to the current market price of 1.47 USD, Femasys Inc is Overvalued by 1%.

Key Points:
FEMY Intrinsic Value
Base Case
1.46 USD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Femasys Inc

Backtest FEMY Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling FEMY stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Femasys Inc's business.

What risks and challenges
does Femasys Inc face in the near future?

Summarize the latest earnings report
of Femasys Inc.

Provide P/E
for Femasys Inc and its competitors.

Financials

Balance Sheet Decomposition
Femasys Inc

Current Assets 10.2m
Cash & Short-Term Investments 8.7m
Receivables 103.6k
Other Current Assets 1.4m
Non-Current Assets 4.6m
PP&E 3.7m
Intangibles 390
Other Non-Current Assets 937k
Current Liabilities 2.2m
Accounts Payable 851.9k
Accrued Liabilities 569.4k
Other Current Liabilities 765.6k
Non-Current Liabilities 2.2m
Long-Term Debt 2.2m
Other Non-Current Liabilities 54k
Efficiency

Earnings Waterfall
Femasys Inc

Revenue
1.1m USD
Cost of Revenue
-376.2k USD
Gross Profit
708.2k USD
Operating Expenses
-13.8m USD
Operating Income
-13.1m USD
Other Expenses
334.4k USD
Net Income
-12.7m USD

Free Cash Flow Analysis
Femasys Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

FEMY Profitability Score
Profitability Due Diligence

Femasys Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative Operating Income
27/100
Profitability
Score

Femasys Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

FEMY Solvency Score
Solvency Due Diligence

Femasys Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
53/100
Solvency
Score

Femasys Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FEMY Price Targets Summary
Femasys Inc

Wall Street analysts forecast FEMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FEMY is 8.67 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
244% Upside
Average
Price Target
8.67 USD
490% Upside
Highest
Price Target
12.6 USD
757% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

FEMY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

FEMY Price
Femasys Inc

1M 1M
-17%
6M 6M
-3%
1Y 1Y
+24%
3Y 3Y
-88%
5Y 5Y
-88%
10Y 10Y
-88%
Annual Price Range
1.47
52w Low
0.306
52w High
3.89
Price Metrics
Average Annual Return -72.1%
Standard Deviation of Annual Returns 7.56%
Max Drawdown -97%
Shares Statistics
Market Capitalization 31.8m USD
Shares Outstanding 21 649 600
Percentage of Shares Shorted 2.5%

FEMY Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Femasys Inc Logo
Femasys Inc

Country

United States of America

Industry

Health Care

Market Cap

31.8m USD

Dividend Yield

0%

Description

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. The company is headquartered in Suwanee, Georgia. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. FemaSeed is an artificial insemination infertility treatment. The firm also offers FemVue Saline-Air device for diagnosis of infertility and FemCerv Endocervical Sampler for diagnosis of cervical cancer. FemCerv is a sterile, single-use disposable endocervical curettage product that can be used to sample cervical cells and tissue, including in support of further testing following an abnormal Pap test to assess for any problems such as cancer, in a relatively pain-free office procedure.

Contact

GEORGIA
Suwanee
3950 Johns Creek Ct Ste 100
+17705003910.0
http://www.femasys.com/

IPO

2021-06-18

Employees

24

Officers

Founder, President, CEO & Director
Ms. Kathy Lee-Sepsick
Chief Financial Officer
Mr. Dov Elefant
COO, Senior VP & Secretary
Mr. Daniel Scott Currie
Vice President of Counsel & Intellectual Property
Ms. Mary An Merchant J.D., Ph.D.
Chief Medical Advisor
Dr. Jeffrey Marcus M.D., M.S.
Senior VP of Regulatory & Clinical Affairs
Ms. Christine Thomas
Show More
Chief Medical Officer
Dr. James H. Liu M.D.
Chief Commercial Officer
Mr. Richard Spector
Show Less

See Also

Discover More
What is the Intrinsic Value of one FEMY stock?

The intrinsic value of one FEMY stock under the Base Case scenario is 1.46 USD.

Is FEMY stock undervalued or overvalued?

Compared to the current market price of 1.47 USD, Femasys Inc is Overvalued by 1%.